A synonymous splice site mutation in IL2RG gene causes late-onset combined immunodeficiency.
Atypical
IL2RG
Leaky
Synonymous mutation
X-linked severe combined immunodeficiency
Journal
International journal of hematology
ISSN: 1865-3774
Titre abrégé: Int J Hematol
Pays: Japan
ID NLM: 9111627
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
09
11
2018
accepted:
27
02
2019
revised:
27
02
2019
pubmed:
10
3
2019
medline:
3
5
2019
entrez:
10
3
2019
Statut:
ppublish
Résumé
X-Linked severe combined immunodeficiency (X-SCID) is a severe form of primary immunodeficiency characterized by absence of T cells and NK cells. X-SCID is caused by a loss-of-function mutation in the IL2RG gene that encodes common gamma chain (γc), which plays an essential role in lymphocyte development. We report the first case of hypomorphic X-SCID caused by a synonymous mutation in the IL2RG gene leading to a splice anomaly, in a family including two patients with diffuse cutaneous warts, recurrent molluscum contagiosum, and mild respiratory infections. The mutation caused aberrant splicing of IL2RG mRNA, subsequently resulted in reduced γc expression. The leaky production of normally spliced IL2RG mRNA produced undamaged protein; thus, T cells and NK cells were generated in the patients. Functional assays of the patients' T cells and NK cells revealed diminished cytokine response in the T cells and absent cytokine response in the NK cells. In addition, the TCR repertoire in these patients was limited. These data suggest that a fine balance between aberrant splicing and leaky production of normally spliced IL2RG mRNA resulted in late-onset combined immunodeficiency in these patients.
Identifiants
pubmed: 30850927
doi: 10.1007/s12185-019-02619-9
pii: 10.1007/s12185-019-02619-9
doi:
Substances chimiques
IL2RG protein, human
0
Interleukin Receptor Common gamma Subunit
0
RNA Splice Sites
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
603-611Subventions
Organisme : Japan Society for the Promotion of Science
ID : 2299310
Organisme : Japan Agency for Medical Research and Development
ID : JP18kk0205002
Organisme : Japan Agency for Medical Research and Development
ID : JP18ek0109179
Références
Clin Immunol. 2000 Apr;95(1 Pt 1):33-8
pubmed: 10794430
Clin Immunol. 2000 Apr;95(1 Pt 1):39-50
pubmed: 10794431
Microbes Infect. 2002 Dec;4(15):1545-58
pubmed: 12505527
Hum Mutat. 2004 May;23(5):522-3
pubmed: 15108287
J Dtsch Dermatol Ges. 2006 May;4(5):417-20
pubmed: 16686610
Nucleic Acids Res. 2007;35(18):5995-6003
pubmed: 17726045
J Allergy Clin Immunol. 2007 Oct;120(4):892-9
pubmed: 17825895
Blood. 2008 Nov 15;112(10):4090-7
pubmed: 18728247
Nucleic Acids Res. 2009 May;37(9):e67
pubmed: 19339519
Nat Rev Immunol. 2009 Jul;9(7):480-90
pubmed: 19543225
J Clin Immunol. 2012 Aug;32(4):690-7
pubmed: 22460439
J Clin Invest. 2012 Oct;122(10):3769-80
pubmed: 23006327
J Allergy Clin Immunol. 2013 May;131(5):1437-40.e5
pubmed: 23273952
Haematologica. 2013 Jul;98(7):1030-8
pubmed: 23403317
Eur J Immunol. 2014 Oct;44(10):3129-40
pubmed: 25042067
JAMA. 2014 Aug 20;312(7):729-38
pubmed: 25138334
Int J Immunogenet. 2015 Feb;42(1):11-4
pubmed: 25443657
J Clin Immunol. 2015 Jul;35(5):449-53
pubmed: 26076747
J Clin Immunol. 2015 Oct;35(7):610-4
pubmed: 26407811
J Clin Immunol. 2018 Apr;38(3):300-306
pubmed: 29671114
J Clin Immunol. 2018 May;38(4):527-536
pubmed: 29948574
Hum Mol Genet. 1993 Aug;2(8):1099-104
pubmed: 8401490
Cell. 1993 Apr 9;73(1):147-57
pubmed: 8462096
Blood. 1997 Mar 15;89(6):1968-77
pubmed: 9058718
J Clin Invest. 1997 Dec 15;100(12):3036-43
pubmed: 9399950